All Stories

  1. PREDICTORS OF SUCCESSFUL LABOR PREINDUCTION WITH MIFEPRISTONE
  2. PLASMA LEVELS OF CELL ADHESION MOLECULES IN NORMAL PREGNANCY AND PREECLAMPSIA
  3. A randomised controlled trial of outpatient mifepristone usage for cervical ripening.
  4. Comparative evaluation of test systems for determining premature rupture of membranes
  5. Obstetric and neonatal outcomes of different management strategies in fetal macrosomia
  6. CURRENT STATE OF ANESTHESIA FOR LABOR
  7. Cell subpopulation composition and cytokine content in peripheral blood before spontaneous and induced labor
  8. Comparison of the course and outcomes of pregnancies complicated by hypertensive disorders
  9. Regulation of the Placental Renin-Angiotensin-Aldosterone System in Early- and Late-Onset Preeclampsia
  10. The use of a vaginal therapeutic system with prostaglandin for induction of labor
  11. Antenatal and intrapartum risk factors associated with fetal hypoxia in labor
  12. Initiation of labor activity as a multifactor mechanism of communication between maternal and fetal compartments
  13. Mechanical methods for induction of labor
  14. Diagnostic Potential of Exosomal HypoxamiRs in the Context of Hypoxia–Sumoylation–HypoxamiRs in Early Onset Preeclampsia at the Preclinical Stage
  15. Comparison of outpatient with inpatient mifepristone usage for cervical ripening: study protocol for a randomized controlled trial
  16. Current views on the pathogenesis of fetal growth restriction
  17. The role of cell adhesion molecules in the pathogenesis of preeclampsia
  18. Relationship between the umbilical cord blood acid-base status and neonatal hypoxic-ischemic encephalopathy
  19. Fetal adaptation to cardiotocography as a criterion of fetal condition
  20. The state of and prospects for the introduction of artificial intelligence technologies in obstetric and gynecological practice
  21. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction
  22. Induction of labour before 41 weeks or expectant management until 42 weeks: data from observational studies, randomized trials, systematic reviews and meta-analysis
  23. Ultrasound criteria for estimating the duration of spontaneous vaginal deliveries
  24. Verifying fetal scalp lactate testing results as measured by a portable lactate analyzer
  25. Umbilical cord arterial lactate levels in newborns with and without acidosis
  26. Modern principles of cardiotocography in childbirth
  27. Correlation of cardiotocographic parameters witt the risk of neonatal hypoxic ischemic encephalopathy
  28. Comparison of the efficiency of labor induction in full term and late term pregnancies
  29. Modification of combined spinal-epidural analgesia in labor
  30. SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity
  31. Clinical and morphological features of the placenta in acute intrauterine hypoxia during childbirth
  32. Indicators of umbilical arterial blood acid-base status during spontaneous labor and cesarean section
  33. Comparison of cord blood lactate measurement by gas analyzer and portable electrochemical devices
  34. Content of Free Fetal DNA in Maternal Blood and Expression of DNA Recognition Receptors ZBP-1 in Placental Tissue in Preeclampsia and Preterm Labor
  35. Combination of mifepristone and Dilapan-S is more efficient for labor induction than Dilapan-S alone
  36. Clinical and economic effectiveness of a placental alpha-microglobulin-1 test and that of the clinical diagnosis of premature rupture of membranes
  37. Structural features of fetal membranes in preterm labor
  38. Diagnostic opportunities of echo elastography in obstetrics and gynecology
  39. Ultrasound during labor: techniques and practical application
  40. Umbilical cord blood acid-base balance and gas composition in relation to the use of epidural analgesia in vaginal delivery
  41. Experience of using a double balloon catheter for cervical ripening in the induction of labor
  42. Ultrasound assessment of fetal head position during labor and delivery
  43. Combined use of Dilapan-S and mifepristone for labour induction in nulliparous women
  44. Maternal plasma cell-free DNA in prediction of preeclampsia
  45. Peripheral blood cytokine levels in women according to the phase of the first period of labor
  46. The indicators of acid-base balance and the gas composition of umbilical cord arterial and venous blood in health and fetal hypoxia
  47. The dynamics of renin, angiotensin (1-7) and angiotensin II in severe and moderate preeclampsia
  48. Prevention, the algorithm of reference, anesthesia and intensive care for postpartum hemorrhage. Guidelines
  49. Prediction of and a risk group for delayed labor
  50. Extracellular DNA in the Dynamics of Uncomplicated Pregnancy
  51. Correction to: Abstracts
  52. Ways to standardise of fetometry in Russia: INTERGROWTH-21st project and its implementation
  53. Biochemical tests for the diagnosis of premature rupture of membranes
  54. Synthetic osmotic dilators in the induction of labour—An international multicentre observational study
  55. Abstracts
  56. Dynamics of Renin, Angiotensin II, and Angiotensin (1–7) during Pregnancy and Predisposition to Hypertension-Associated Complications
  57. Umbilical vein aneurysm: A clinical case and a review of literature
  58. Determination of umbilical cord blood acid-base status. Indications and techniques
  59. A comparison of tocolysis with nifedipine and atosiban in preterm labor
  60. The role of extracellular fetal DNA in predicting the great obstetric syndromes
  61. Features of the myometrial status during cesarean section with regard to amniorrhea and birth activity: A clinical and morphological study
  62. A change in the concentration of extracellular DNA during pregnancy
  63. Corrigendum to “Identification of potential early biomarkers of preeclampsia” [Placenta (2018) 61–71]
  64. Modern tocolysis and adverse effects of tocolytics
  65. Identification of potential early biomarkers of preeclampsia
  66. Giant hemangioma of the placenta
  67. DAI-1 Receptor Expression in Placenta in Earlyand Late-Onset Preeclampsia
  68. Efficacy of atosiban for threatened preterm birth
  69. Outcomes of mifepristone usage for cervical ripening and induction of labour in full-term pregnancy. Randomized controlled trial
  70. Perinatal prevention of diseases caused by Group B streptococcus (clinical protocol)
  71. Maternal and perinatal outcomes in early and late preeclampsia
  72. Umbilical cord blood cytokines during spontaneous labor and caesarean section
  73. Synthetic Osmotic Dilator Prior to Induction of Labor: Outcomes From International Observational E-Registry [13C]
  74. Morphological Features of Mesenhymal Stroma Cells of Chorionic Villi
  75. Diagnosis and treatment of intrahepatic cholestasis of pregnancy. Clinical recommendations
  76. 4 Oral Presentations
  77. 5 Poster Presentations
  78. COMPAREMENT OF LOCALIZA ATOSIBAN AND HEXOPRENALINE IN PREMATURE DELIVERY BEFORE 32 AND AFTER 32 WEEKS OF PREGNANCY
  79. Течение родов в современных условиях
  80. Fetal oxytocin levels at term with and without labour
  81. Current views of the etiology of prolonged pregnancy
  82. Misoprostol Vaginal Insert in Labor Induction: A Cost–Consequences Model for 5 European Countries—An Economic Evaluation Supported with Literature Review and Retrospective Data Collection
  83. The course and outcomes of labor in relation to management tactics during prolonged pregnancy
  84. The clinical and economic efficiency of direct electrocardiography with ST-segment analysis in the evaluation of fetal status
  85. Influence of magnesium therapy on ion homeostasis in women with preeclampsia
  86. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor
  87. Caspase Expression in Placental Terminal Villi in Spontaneous and Induced Pregnancy
  88. Misoprostol Vaginal Insert Pharmacoeconomic Model for 5 European Countries
  89. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery
  90. O658 MOLECULAR GENETIC RISK FACTORS OF OBSTETRICAL COMPLICATIONS AND ASSISTED REPRODUCTIVE TECHNOLOGIES
  91. Expression of proliferative receptors on trophoblastic cells in women after assisted reproductive technologies
  92. Expression of Carbohydrate Metabolism Markers in Full-Term Spontaneous and Induced Pregnancy
  93. Markers of Transmembrane and Energy Exchange in Cells of Terminal Placental Villi in Spontaneous and Induced Pregnancy
  94. Peroxisome Proliferator-Activated Receptors of Trophoblast Cells in Miscarriage
  95. First trimester serum and ultrasound marker distribution in singleton pregnancy conceived with assisted reproductive technology
  96. Mifepristone versus intracervical prostaglandin E2 gel for cervical ripening and labor induction
  97. Thrombophilic genetic polymorphisms and placental histomorphology in pregnancies conceived by assisted reproductive technology
  98. 1 THROMBOPHILIA POLYMORPHISMS IN WOMEN WITH PREGNANCY CONCEIVED BY ASSISTED REPRODUCTIVE TECHNOLOGY
  99. Features of antibacterial therapy intraamniotic infections
  100. Treatment of the uteroplacental insufficiency, caused by intraamniotic infection